Welcome to EXIR PHARMACEUTICAL CO. WebSite
|
» NEWS
AND EVENTS |
|
|
|
The gathering was held from 24th August 2008 till 26th August in Tehran...
|
|
|
Welcome to EXIR PHARMACEUTICAL CO. WebSite
|
»
ARTICLE OF THE DAY |
|
|
|
Comparison of two treatment regimens in symptomaticaliy homogenous gerd patient
Populations : pantoprazole relieves gastrointestinal symptoms significantily better than omeprazole
|
|
|
|
Welcome to EXIR PHARMACEUTICAL CO. WebSite
|
»
EXIR PRODUCTS IN A GLANCE |
|
|
|
|
|
Welcome to EXIR PHARMACEUTICAL CO. WebSite
|
|
»
EXIR PRODUCTS
|
|
|
|
|
| |
|
|
|
Insulin isophane (NPH) - Human-Exir |
|
|
|
|
Generic Name: |
|
|
Insulin isophane (NPH) - Human |
|
|
Dosage: |
|
|
100 IU/1ml,10 ml vial |
|
|
Lansulin® causes a fall in blood glucose concentration. It
facilitates glucose transport into cells and glucose metabolism
within them.
|
|
|
|
|
|
Multi-Sanostol |
|
|
|
|
Generic Name: |
|
|
Multi-Sanostol® |
|
|
Dosage: |
|
|
200 g Syrup |
|
|
Multi-Sanostol® provides all 9 vitamins essential during child growth and development as well as calcium. It prevents rickets as well as disturbance in child growth development, promotes the formation of both bone and teeth.
|
|
|
|
|
|
|
|
|
|
Cefezolin-Exir |
|
|
|
|
Generic Name: |
|
|
Cefazolin |
|
|
Dosage: |
|
|
1000 mg vial/12 s |
|
|
Cefazex® is a first- generation cephalosporin which like other
cephalosporin and penicllins, kills bacteria by interfering in
the synthesis of the bicterial cell wall. Cefazex® binds with
high affinity t o penicllin binding. Proteins (PBPs) in the
baclerial cell wall. this process interferes with peptidoglycan
synthesis. Peptidoglycan is a heteropolymric structure that
provides the cell wall with mechanical stability.
As a resulte bacterial cell wall is weakened, and the call
swells and then ruptures. Cefazex® is bactericidal against a
broad spectrum of bacteria at easily achievable plasmaconcenterations.
The low affinity pencillin- binding protein
PBP’s2a. is responsible for the Cefazex® resistance observed
in some organisms.
|
|
|
|
|
|
Amikacin-Exir |
|
|
|
|
Generic Name: |
|
|
Amikacin |
|
|
Dosage: |
|
|
-- |
|
|
Lorikacin® is active against a wide range of aerobic Gramnegative
bacilli. Lorikacin® binds irreversibly to the 30s
subunit of the bacterial ribosome, blocking protein synthesis
by inhibiting the movement of peptidyl-t RNA associated
with translocation as well as increasing the frequency of
misreading of the genetic code owing to incorrect codonanticodon
interaction. The effect is bactericidal.
|
|
|
|
|
|
|
|
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 
|
|
|
|
|
|
|
